<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0020265"><a href="http://purl.obolibrary.org/obo/MONDO_0020265">MONDO:0020265</a></h3>
<p><strong>Label:</strong> mitochondrial disease with eye involvement</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0016816">MONDO:0016816</a> (Leigh syndrome with nephrotic syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0016815">MONDO:0016815</a> (Leigh syndrome with leukodystrophy), <a href="http://purl.obolibrary.org/obo/MONDO_0018859">MONDO:0018859</a> (Leigh disease), <a href="http://purl.obolibrary.org/obo/MONDO_0020478">MONDO:0020478</a> (Leber plus disease), <a href="http://purl.obolibrary.org/obo/MONDO_0009723">MONDO:0009723</a> (Leigh syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0010788">MONDO:0010788</a> (Leber hereditary optic neuropathy),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_255241">Orphanet:255241</a>, <a href="http://purl.obolibrary.org/obo/OMIM_220111">OMIM:220111</a>, <a href="http://www.orpha.net/ORDO/Orphanet_255210">Orphanet:255210</a>, <a href="http://purl.obolibrary.org/obo/OMIM_607426">OMIM:607426</a>, <a href="http://www.orpha.net/ORDO/Orphanet_255249">Orphanet:255249</a>, <a href="http://purl.obolibrary.org/obo/OMIM_500001">OMIM:500001</a>, <a href="http://purl.obolibrary.org/obo/OMIM_308905">OMIM:308905</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616277">OMIM:616277</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614652">OMIM:614652</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99718">Orphanet:99718</a>, <a href="http://www.orpha.net/ORDO/Orphanet_506">Orphanet:506</a>, <a href="http://purl.obolibrary.org/obo/OMIM_535000">OMIM:535000</a>, <a href="http://purl.obolibrary.org/obo/OMIM_165200">OMIM:165200</a>, <a href="http://www.orpha.net/ORDO/Orphanet_104">Orphanet:104</a>, <a href="http://purl.obolibrary.org/obo/OMIM_256000">OMIM:256000</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0002151">HP:0002151</a> (Increased serum lactate) and <a href="http://purl.obolibrary.org/obo/HP_0003808">HP:0003808</a> (Abnormal muscle tone) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 46.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000478">HP:0000478</a> (Abnormality of the eye) and <a href="http://purl.obolibrary.org/obo/HP_0002151">HP:0002151</a> (Increased serum lactate) and <a href="http://purl.obolibrary.org/obo/HP_0003808">HP:0003808</a> (Abnormal muscle tone) 44.96%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000478">HP:0000478</a> (Abnormality of the eye) 41.11%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 39.40%</li>
<li>Thing 39.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 39.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002151">HP:0002151</a> (Increased serum lactate) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 39.15%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002151">HP:0002151</a> (Increased serum lactate) and <a href="http://purl.obolibrary.org/obo/HP_0003011">HP:0003011</a> (Abnormality of the musculature) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 39.15%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002151">HP:0002151</a> (Increased serum lactate) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 38.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002151">HP:0002151</a> (Increased serum lactate) and <a href="http://purl.obolibrary.org/obo/HP_0003808">HP:0003808</a> (Abnormal muscle tone) 38.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000572">HP:0000572</a> (Visual loss) and <a href="http://purl.obolibrary.org/obo/HP_0011805">HP:0011805</a> (Abnormality of muscle morphology) 38.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000478">HP:0000478</a> (Abnormality of the eye) and <a href="http://purl.obolibrary.org/obo/HP_0002151">HP:0002151</a> (Increased serum lactate) 36.90%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) 36.85%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 34.90%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003011">HP:0003011</a> (Abnormality of the musculature) 34.35%</li>
</ul>
</body>
</html>
